An insulin pen is an insulin injection device used for injecting insulin during the treatment of diabetics. The insulin pen eliminates the cumbersome process for diabetic patients to use a syringe to extract insulin from the insulin bottle, making the insulin injection process simpler and more concealed, and eliminating the embarrassment of diabetic patients injecting insulin in public places.
The structure of an insulin pens
The appearance of an insulin injection pen looks like an ordinary and thick pen. It is composed of an insulin refill and a metering dial that are sold as a complete set or purchased separately, and are used together with disposable needles. insulin pens produced by many companies must be used in conjunction with their respective products.
Innovation in insulin pens
Reusable insulin pen
It consists of an injection pen and a refill (with insulin inside). Once the insulin in the refill is used up, it needs to be replaced with a new refill. The injection pen is reusable, and the insulin pens can be used for many years or even a lifetime.
Disposable insulin pen
It is a disposable injection device prefilled with 3 ml (containing 300 units) of insulin. There is no need to replace the refill and it can be discarded directly after use. This type of insulin injection pen is simple and hygienic.
Insulin needleless injection pen
The working principle is to use high pressure to cause liquid medicine to pass through extremely fine holes to produce liquid injection, which penetrates the skin and is sprayed into the subcutaneous tissue, greatly improving the absorption effect. Needleless insulin syringes avoid needle holes and pain, avoid local fat hyperplasia caused by long-term injections, and reduce edema. However, consumables (ampules and adapters) need to be replaced regularly, which costs a lot.
Market layout of insulin pens
Insulin pen market size
According to relevant reports, insulin pen users are mainly used by patients with type 2 diabetes, and type 2 diabetes mostly occurs after the age of 35 to 40. Therefore, the aging of the population in our country is accelerating and the number of diabetic patients is increasing. In 2019, the number of diabetic patients in my country was 1.2 There are about 100 million people, among which type 2 diabetes patients account for a high proportion. Due to the large number of diabetic patients in my country, and the number is still growing rapidly, the market demand for insulin pens has increased accordingly. It is estimated that by the end of 2022, the number of patients treated with insulin pens in my country will be approximately 10 million, and the market size is expected to be approximately 500 billion.
Insulin pen global market
From a production perspective, the global insulin pen market is mainly occupied by three foreign companies, namely Novo Nordisk of Denmark, Sanofi of France, and Eli Lilly of the United States. The insulin series products of the above three companies account for 89% of the global insulin market. % share, among which Novo Nordisk is the world's largest insulin pen manufacturer, with a current market share of more than 45%, and an average annual production and sales of approximately 780 million insulin pens.
In the realm of diabetes management, the tresiba flextouch pen stands as a prominent innovation in insulin delivery systems. This state-of-the-art insulin pen not only simplifies the injection process for patients but also enhances the overall experience with its precision engineering and user-friendly design. As we delve into the evolution of insulin pens and their integral role in diabetes care, let's explore how the tresiba flextouch pen fits into this dynamic landscape.
The Evolving Landscape of insulin pens
Traditionally, insulin pens have transformed the way insulin-dependent diabetics manage their condition, offering a more discreet and straightforward alternative to syringes. The tresiba flextouch pen, in particular, embodies the pinnacle of this innovation, combining a sleek design with advanced features to ensure accurate dosing and a comfortable injection experience.
Innovative Features of the Tresiba Flextouch Pen
Among the various insulin pen designs, the tresiba flextouch pen distinguishes itself with its intuitive metered dose dial, allowing for precise adjustments to insulin intake. Its reusable pen body ensures longevity, reducing waste while maintaining the ease of replacing insulin cartridges when needed. This design philosophy aligns perfectly with the reusable insulin pen concept, where the pen becomes a long-term companion for patients, with only the insulin refills being periodically changed.
Comparing to Other Pen Technologies
When juxtaposed against disposable insulin pens or needleless injection pens, the tresiba flextouch pen strikes a balance between convenience and sustainability. While disposable pens offer a one-and-done solution, they lack the eco-friendliness and long-term cost-effectiveness of a reusable pen like the Tresiba Flextouch. Meanwhile, needleless pens eliminate the discomfort of injections, but their higher maintenance costs through frequent consumable replacements might be a deterrent for some users.
Market Impact and Future Prospects
The global insulin pen market, dominated by giants such as Novo Nordisk, Sanofi, and Eli Lilly, witnesses a steady rise in demand fueled by the increasing prevalence of type 2 diabetes worldwide. Novo Nordisk, with its extensive portfolio including advanced pens like the tresiba flextouch, commands a significant share of the market, reflecting the trust placed in their innovative insulin delivery solutions.
Considering the demographic shifts towards an aging population and the surge in diabetes cases, the tresiba flextouch pen, with its precision, convenience, and adaptability to patient needs, is poised to play a pivotal role in meeting the growing demand for effective insulin delivery systems. As the market continues to expand,Expected that pens integrating advanced technology like the tresiba flextouch will spearhead the next wave of diabetes management tools, enhancing patient compliance and overall health outcomes.
In summary, the tresiba flextouch pen represents not just an insulin delivery device but a cornerstone of modern diabetes care, blending user-centric design with the precision required for optimal diabetes management. Its position within the insulin pen market underscores the importance of continuous innovation in addressing the evolving needs of the diabetes community worldwide.